中文版 | English
题名

Interleukin-33 and thymic stromal lymphopoietin are primary cytokines involved in the Th1/Th2 inflammatory response in chronic secretory otitis media

作者
通讯作者Jiang,Hongyan; Hu,Genwen
发表日期
2022
DOI
发表期刊
ISSN
1721-727X
EISSN
2058-7392
卷号17
摘要
Background: T-helper (Th)1/Th2 inflammatory responses are responsible for secretory otitis media (SOM) development. However, the mechanisms underlying these immune responses remain unknown. This study aims to identify the primary cytokines that play essential roles in chronic SOM. Methods: Two groups were established for the present study: chronic SOM group (n = 21) and control group (n = 10). The middle ear effusion and serum samples of the expression cytokines (interleukin IL-2, IL-4, IL-5, IL-13, IL-17, IL-25, IL-33, interferon [IFN]-γ, thymic stromal lymphopoietin [TSLP], immunoglobulin IgE, and pepsins) were analyzed by enzyme-linked immunosorbent assay. Results: The levels of IL-4, IL-5, IL-13, IL-17, IL-25, IFN-γ, TLSP, pepsins, IL-2, and IL-33 (all, p < 0.001) were higher in middle ear effusion, when compared to those in serum, in chronic SOM group (non-paired sample). However, there was no significant difference in serum expression for those cytokines compared chronic SOM group and control group. The paired sample expression for IL-33 and TLSP (both, p = 0.046) were higher compared the effusion and serum in chronic SOM group. Conclusions: IL-33 produces inflammatory cytokines, such as IL-1b, IL-6, TNF-α, IL-10, IL-4, and TGF-β, which through nucleus into cytoplasm causing inflammatory responses. The present study revealed that IL-33 also produce IL-17, IL-4, IL-5, and IL-13 inflammatory factors, triggering an inflammatory response. Study reported that the combined stimulation of TSLP and IL-33 elicits an approximately 10-fold increase in cytokine production, when compared to the stimulation of IL-33 alone. This suggests that IL-33 and TLSP may be the primary cytokines involved in Th1/Th2 inflammatory responses in chronic SOM.
关键词
相关链接[Scopus记录]
收录类别
语种
英语
学校署名
第一 ; 通讯
资助项目
Cultivating Fund Project of Shenzhen People's Hospital[SYKYPY201933]
WOS研究方向
Immunology
WOS类目
Immunology
WOS记录号
WOS:000921237900029
出版者
Scopus记录号
2-s2.0-85131186691
来源库
Scopus
引用统计
被引频次[WOS]:0
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/336312
专题南方科技大学第一附属医院
作者单位
1.Department of Otorhinolaryngology Head and Neck Surgery,Shenzhen people’s Hospital,The Second Clinical Medical College,Jinan University,The First Affiliated Hospital,Southern University of Science and Technology,Guangdong,China
2.Department of Otorhinolaryngology Head and Neck Surgery,The First Affiliated Hospital of Jinan University,Guangdong,China
3.Department of Otorhinolaryngology Head and Neck Surgery,Hainan General Hospital,Hainan,China
4.Department of Radiology,Shenzhen People’s Hospital,The Second Clinical Medical College,Jinan University,The First Affiliated Hospital,Southern University of Science and Technology,Guangdong,China
第一作者单位南方科技大学第一附属医院
通讯作者单位南方科技大学第一附属医院
第一作者的第一单位南方科技大学第一附属医院
推荐引用方式
GB/T 7714
Liao,Zhifang,Tu,Bo,Sun,Liang,et al. Interleukin-33 and thymic stromal lymphopoietin are primary cytokines involved in the Th1/Th2 inflammatory response in chronic secretory otitis media[J]. European Journal of Inflammation,2022,17.
APA
Liao,Zhifang,Tu,Bo,Sun,Liang,Dong,Chang,Jiang,Hongyan,&Hu,Genwen.(2022).Interleukin-33 and thymic stromal lymphopoietin are primary cytokines involved in the Th1/Th2 inflammatory response in chronic secretory otitis media.European Journal of Inflammation,17.
MLA
Liao,Zhifang,et al."Interleukin-33 and thymic stromal lymphopoietin are primary cytokines involved in the Th1/Th2 inflammatory response in chronic secretory otitis media".European Journal of Inflammation 17(2022).
条目包含的文件
条目无相关文件。
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[Liao,Zhifang]的文章
[Tu,Bo]的文章
[Sun,Liang]的文章
百度学术
百度学术中相似的文章
[Liao,Zhifang]的文章
[Tu,Bo]的文章
[Sun,Liang]的文章
必应学术
必应学术中相似的文章
[Liao,Zhifang]的文章
[Tu,Bo]的文章
[Sun,Liang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。